From Scientific Promise to Commercial Reality: How Should the Industry Prioritise the Next Generation of Radioligand Therapy Opportunities?

Name: From Scientific Promise to Commercial Reality: How Should the Industry Prioritise the Next Generation of Radioligand Therapy Opportunities?
Start: 2026-12-03T16:00
Location: Renaissance London Heathrow Hotel

Targeted Radiopharmaceuticals Summit EU 2026 · 3 December 2026 · 16:00

From Scientific Promise to Commercial Reality: How Should the Industry Prioritise the Next Generation of Radioligand Therapy Opportunities? was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 3 December 2026 in London, with 1 speaker on record.

Speakers

Ana Filipa Fonseca — Speaker Director, Global RLT Strategy and Early Portfolio, Novartis AG